article thumbnail

Sales Strategy For Milk Products Insights

Contrarian Sales Techniques

After reading the "sales strategy for milk products" article , I learned some valuable insights that I believe can be applied to any industry, not just the milk product industry. Understanding these groups will allow you to create targeted marketing campaigns and tailor your sales pitch to meet their needs.

article thumbnail

Novartis takes aim at MS blockbuster Tysabri in US and Europe

pharmaphorum

The looming competition piles further pressure on Biogen, whose MS franchise is already beset by generic competition to oral therapy Tecfidera (dimethyl glutamate), while its attempt to build a market for Alzheimer’s therapy Aduhelm (aducanumab) has ended in failure.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 Home Security Sales Tips You’ve Probably Never Tried

Spotio

billion by 2027—a 48% jump from where the industry was last year, in 2022. Keep reading for our best tips regarding home security sales. In this section, we share 11 tips to help you make more home security sales. Home Security Sales Tip 1: Start With Your Target Audience Who are you trying to sell to?

Sales 40
article thumbnail

Novartis facing Gilenya generics again as Supreme Court lifts stay

pharmaphorum

Novartis’ hopes that the Supreme Court would protect its big-selling multiple sclerosis drug Gilenya from generic competition have been dashed. 9,187,405, granted in 2015, which comes to an end in 2027. If they do so, Novartis has predicted it will lose $300 million in sales over the remainder of this year.

article thumbnail

Supreme court throws Novartis a lifeline for Gilenya defense

pharmaphorum

In a dramatic change in fortunes, Novartis has won a major victory in its bid to defend oral multiple sclerosis therapy Gilenya from early generic competition in the US. Sales in the first half of this year fell 19% to $1.16 Gilenya made revenues of $2.8

article thumbnail

Polpharma in pole position for biosimilar Tysabri in Europe

pharmaphorum

Tysabri made worldwide sales of just under $2.1 It had expected the drug would not face biosimilar competition in Europe until at least 2027. billion last year, split roughly half and half between the US and the rest of the world, and is Biogen’s biggest seller. Europe accounted for an estimated $850 million of the total.

article thumbnail

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

Evolve Your Success

He provides a fascinating glimpse into what it takes to excel in the field of medical device sales, emphasizing the importance of authenticity and passion. Blake has a unique case because he was a cardiac, cath lab, critical care, and surgery nurse who got into medical sales. People come from sales, clinical, and engineers.